Robert H Scannevin Selected Research

Reserpine (Serpasil)

2/2012

Design and characterization of optimized adenosine A₂A/A₁ receptor antagonists for the treatment of Parkinson's disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Robert H Scannevin Research Topics

Disease

10	Multiple Sclerosis 01/2017 - 03/2011
6	Parkinson Disease (Parkinson's Disease) 04/2022 - 02/2012
6	Alzheimer Disease (Alzheimer's Disease) 01/2018 - 10/2011
5	Neurodegenerative Diseases (Neurodegenerative Disease) 04/2022 - 04/2012
4	Synucleinopathies 04/2022 - 10/2016
3	Neuroinflammatory Diseases 10/2016 - 03/2011
3	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 08/2015 - 03/2011
2	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2021 - 01/2015
2	Ischemic Stroke 12/2008 - 01/2008
2	Stroke (Strokes) 12/2008 - 04/2007
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2018
1	Huntington Disease (Huntington's Disease) 01/2018
1	Proteostasis Deficiencies 01/2018
1	Fibrosis (Cirrhosis) 10/2017
1	Neoplasms (Cancer) 10/2017
1	Gliosis 10/2016
1	Relapsing-Remitting Multiple Sclerosis 08/2015
1	Flushing 10/2013
1	Catalepsy 02/2012
1	Inflammation (Inflammations) 03/2011
1	Disease Progression 03/2011
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 12/2008
1	Ischemia 12/2008
1	Infarction (Infarctions) 12/2008
1	Cerebral Hemorrhage 12/2008
1	Brain Ischemia (Cerebral Ischemia) 01/2008

Drug/Important Bio-Agent (IBA)

11	Dimethyl FumarateIBA 01/2021 - 03/2011
4	SynucleinsIBA 04/2022 - 10/2016
3	LipidsIBA 04/2022 - 12/2018
3	Transcription Factors (Transcription Factor)IBA 10/2016 - 03/2011
3	FumaratesIBA 04/2016 - 03/2011
3	Neuroprotective AgentsIBA 08/2015 - 03/2011
2	Carrier Proteins (Binding Protein)IBA 04/2022 - 12/2018
2	Stearoyl-CoA DesaturaseIBA 04/2022 - 01/2022
2	Biological ProductsIBA 01/2021 - 01/2008
2	ethyl fumarateIBA 01/2021 - 01/2015
2	Proteins (Proteins, Gene)FDA Link 01/2018 - 04/2016
2	aducanumabIBA 01/2017 - 01/2016
2	Pharmaceutical PreparationsIBA 10/2016 - 02/2012
2	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 04/2016 - 10/2011
2	Amyloid (Amyloid Fibrils)IBA 04/2016 - 01/2016
2	monomethyl fumarateIBA 08/2015 - 10/2013
2	AntioxidantsIBA 04/2012 - 03/2011
1	Fatty Acids (Saturated Fatty Acids)IBA 12/2018
1	Matrix Metalloproteinases (MMPs)IBA 10/2017
1	Therapeutic UsesIBA 01/2017
1	BIIB042IBA 04/2016
1	Peptides (Polypeptides)IBA 04/2016
1	Protein Isoforms (Isoforms)IBA 04/2016
1	SaltsIBA 01/2015
1	Interferon-betaIBA 07/2014
1	Amyloid beta-PeptidesIBA 04/2014
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 10/2013
1	ProstaglandinsIBA 10/2013
1	Prostaglandin D2IBA 10/2013
1	Oxidopamine (6 Hydroxydopamine)IBA 02/2012
1	Reserpine (Serpasil)FDA Link 02/2012
1	Adenosine (Adenocard)FDA LinkGeneric 02/2012
1	Haloperidol (Haldol)FDA LinkGeneric 02/2012
1	AcidsIBA 10/2011
1	Myelin-Oligodendrocyte GlycoproteinIBA 03/2011
1	Free RadicalsIBA 03/2011
1	Minocycline (Cyclops)FDA LinkGeneric 12/2008
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2008
1	Matrix Metalloproteinase InhibitorsIBA 01/2008
1	Plasminogen Activators (Plasminogen Activator)IBA 04/2007

Therapy/Procedure

10	Therapeutics 04/2022 - 04/2007
1	Oral Administration 02/2012